137 related articles for article (PubMed ID: 15557156)
1. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells.
Reich-Zeliger S; Bachar-Lustig E; Gan J; Reisner Y
J Immunol; 2004 Dec; 173(11):6654-9. PubMed ID: 15557156
[TBL] [Abstract][Full Text] [Related]
2. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
[TBL] [Abstract][Full Text] [Related]
3. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.
Reich-Zeliger S; Zhao Y; Krauthgamer R; Bachar-Lustig E; Reisner Y
Immunity; 2000 Oct; 13(4):507-15. PubMed ID: 11070169
[TBL] [Abstract][Full Text] [Related]
4. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.
Bachar-Lustig E; Reich-Zeliger S; Reisner Y
Blood; 2003 Sep; 102(6):1943-50. PubMed ID: 12775573
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells.
Reich-Zeliger S; Bachar-Lustig E; Bar-Ilan A; Reisner Y
J Immunol; 2007 Nov; 179(10):6389-94. PubMed ID: 17982025
[TBL] [Abstract][Full Text] [Related]
6. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
Fink PJ; Rammensee HG; Bevan MJ
J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
[TBL] [Abstract][Full Text] [Related]
7. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
8. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
9. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
10. Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.
Qi Y; Berg R; Singleton MA; Debrick JE; Staerz UD
J Exp Med; 1996 May; 183(5):1973-80. PubMed ID: 8642307
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
Ogasawara M; Iwabuchi K; Good RA; Onoe K
J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
[TBL] [Abstract][Full Text] [Related]
12. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation.
Reich-Zeliger S; Eidelstein Y; Hagin D; Antebi YE; Seger R; Reisner Y
Transplantation; 2010 Aug; 90(4):380-6. PubMed ID: 20595932
[TBL] [Abstract][Full Text] [Related]
13. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
14. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
[TBL] [Abstract][Full Text] [Related]
15. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
Rich RF; Green WR
J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
[TBL] [Abstract][Full Text] [Related]
17. Induction of B-cell immune tolerance by antigen-modified cytotoxic T lymphocytes.
Nguyen P; Geiger TL
Transplantation; 2010 Mar; 89(6):667-76. PubMed ID: 20065917
[TBL] [Abstract][Full Text] [Related]
18. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
19. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice.
Zhou T; Bluethmann H; Eldridge J; Brockhaus M; Berry K; Mountz JD
J Immunol; 1991 Jul; 147(2):466-74. PubMed ID: 1830064
[TBL] [Abstract][Full Text] [Related]
20. Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow.
Takahashi T; Mafune K; Maki T
J Exp Med; 1990 Sep; 172(3):901-9. PubMed ID: 2143775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
